SCHEMBL8093483

SCHEMBL8093483

NC(=O)c1nc(Nc2ccc3c(c2)nnn3Cc2ccccc2)c2c[c]ccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.46
NAMPT P43490 1/20 0.41
ERBB2 P04626 6/20 0.39
EGFR P00533 5/20 0.39
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC9A1 P19634 1/20 0.38
GRM2 Q14416 1/20 0.38
JAK2 O60674 2/20 0.37
JAK1 P23458 2/20 0.37
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
MAPT P10636 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ERBB4 Q15303 2/20 0.36
JAK3 P52333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081962 0.93 HCAR3 (0.39) HCAR3NAMPTERBB2EGFRLMNA
SCHEMBL8096164 0.83 MAPT (0.36) ERBB2EGFRTP53KDM4EJAK2
SCHEMBL3265691 0.77 MAPT (0.44) TP53KDM4EJAK2MAPTALDH1A1
SCHEMBL8093530 0.75 SIRT2 (0.50) ERBB2EGFRLMNATP53SMN1; SMN2
SCHEMBL2991831 0.73 DYRK1A (0.47) ERBB2EGFRJAK2JAK1
SCHEMBL8147977 0.73 SCN9A (0.50) ERBB2EGFRTP53KDM4EMAPT
SCHEMBL2992809 0.73 AURKA (0.46) ERBB2EGFR
SCHEMBL8093507 0.73 PARP1 (0.37) KDM4EADORA3ADORA2A
SCHEMBL8150035 0.72 CSNK2A1 (0.38) EGFRLMNAGRM2MAPTALDH1A1
SCHEMBL8524532 0.72 SYK (0.46) KDM4EHSD17B10MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6153617-A Irreversible bicyclic inhibitors of tyrosine kinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US claimed
US-6153617-A Irreversible bicyclic inhibitors of tyrosine kinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US disclosed